Takeda
Russell Weiner, PhD, FAAPS is a globally recognized leader in the biopharmaceutical field with over 30 years of expertise in drug development, personalized medicine, regulated bioanalysis, and the development of biomarkers and companion diagnostic assays.
In his most recent role as Head of Oncology and Cell Therapy Clinical Biomarker Sciences and Operations at Takeda, Dr. Weiner established a cutting-edge translational sciences and operations team, including the construction of state-of-the-art biomarker laboratories. This team is tasked with overseeing the development, validation, and analysis of biomarker assays, as well as managing samples, data and vendors.
Dr. Weiner earned his PhD in Biochemistry from Albany Medical College. His career includes leading roles in regulated bioanalysis, translational biomarker sciences, and companion diagnostic development at major organizations such as Bristol-Myers Squibb, Merck, Daiichi Sankyo, the Bill & Melinda Gates Medical Research Institute, and Takeda. His work has significantly advanced personalized medicine approaches for cancer. He played a key role in the development of Erbitux® for oncology and contributed to the advancement of several immuno-therapeutics, including the checkpoint inhibitors Orencia® for rheumatoid arthritis and Nulojix® for kidney transplantation. Dr. Weiner was also instrumental in the development and approval of pioneering checkpoint inhibitors, Yervoy® and Keytruda®, including the associated companion diagnostic assay.
An active member of the American Association of Pharmaceutical Scientists (AAPS) for over 30 years, Dr. Weiner currently serves as AAPS President-Elect. His past contributions include chairing the Biotech Section, serving as a Member-at-Large on the AAPS Board of Directors, and leading the AAPS Annual Meeting, known as PharmSci 360. Known for his sense of humor and dedication to mentorship, Dr. Weiner also serves as Adjunct Faculty in the Department of Pharmaceutics at the University of Florida College of Pharmacy. He frequently travels to universities both domestically and internationally to provide training in soft skills, interview preparation, and career guidance.
Disclosure information not submitted.
Wednesday, October 23, 2024
12:30 PM – 1:25 PM MT